Algo version: 0.98b
Global Health Limited is listed at the NSE Exchange
Global Health Limited [MEDANTA.NS]
NSE Sector: Healthcare Industry:Medical Care Facilities

Is Global Health Limited stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

We cannot find any recorded dividends paid in our systems.

Sorry, we do not have any analyst data for this ticker

We cannot find data for Global Health Limited 10 years ago, but if you had invested on Friday 18th of November 2022 when the price was INR414.15, you would have made a profit of INR696.80 per share or 168.25%

Yes, the average daily trading liquidity for Global Health Limited is INR471 600 thousand. You should therefore be able to get in and out of your positions relatively fast.

Global Health Limited has a normal ratio of the business financed by loans. This puts the company at some risk in periods of high inflation where borrowing costs usually go up. With a normal cash flow to debt ratio of 0.41, the company's ability to pay off the debt is normal. Global Health Limited has a good net profit margin of 14.60% and should have high tolerances against inflation.

We have calculated the inflation risk for Global Health Limited to be low [0.4 of 1]

US inflation for July 2024 was 0.15%. Over the last 12 months, the US inflation is 2.92%. The 10-year treasury yield that indicates the future interest level is currently 3.72 and is down -0.95 over the last 30 days.